Oric Pharmaceuticals, Inc. short interest in 2021
In 2021, Oric Pharmaceuticals, Inc.'s disclosed short interest ran from 9.23% of shares outstanding on 15 Jan 2021 to 6.74% on 31 Dec 2021, a change of -2.49 percentage points. The year's high was 17.15% on 15 Apr 2021 and its low 6.74% on 31 Dec 2021, averaging 10.67% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 49.93 days on 28 May 2021. Full history: Oric Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 9.23% (15 Jan 2021)
- End of year
- 6.74% (31 Dec 2021)
- Change
- -2.49 pp
- High
- 17.15% (15 Apr 2021)
- Low
- 6.74% (31 Dec 2021)
- Average
- 10.67%
- Highest days to cover
- 49.93 (28 May 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 9.23% | 10.27 | results (8-K) |
| 29 Jan 2021 | 11.23% | 9.04 | |
| 12 Feb 2021 | 11.09% | 23.02 | |
| 26 Feb 2021 | 11.23% | 24.92 | |
| 15 Mar 2021 | 11.71% | 20.29 | |
| 31 Mar 2021 | 15.41% | 12.85 | 10-K filed, results (8-K) |
| 15 Apr 2021 | 17.15% | 25.01 | |
| 30 Apr 2021 | 14.96% | 32.10 | |
| 14 May 2021 | 15.20% | 40.60 | 10-Q filed, results (8-K) |
| 28 May 2021 | 14.96% | 49.93 | |
| 15 Jun 2021 | 15.42% | 25.05 | |
| 30 Jun 2021 | 15.02% | 14.19 | |
| 15 Jul 2021 | 8.58% | 12.72 | |
| 30 Jul 2021 | 9.15% | 24.61 | |
| 13 Aug 2021 | 8.52% | 20.61 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 8.21% | 20.75 | |
| 15 Sep 2021 | 7.81% | 21.35 | |
| 30 Sep 2021 | 7.65% | 9.62 | |
| 15 Oct 2021 | 7.50% | 4.22 | |
| 29 Oct 2021 | 7.40% | 17.13 | |
| 15 Nov 2021 | 7.42% | 18.38 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 7.16% | 22.48 | |
| 15 Dec 2021 | 7.27% | 14.36 | |
| 31 Dec 2021 | 6.74% | 14.40 |
See also: Oric Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.